Gambro Healthcare - Inglewood — Inglewood, California

Gambro Healthcare - Inglewood is a clinical research site located in Inglewood, California, United States 90301.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Gambro Healthcare - Inglewood has participated in 1 clinical trials.

Therapeutic areas: End-Stage Kidney Disease.

Sponsors: Abbott.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Inglewood

Browse all research sites in California · View every site in Inglewood

• Daniel Freeman Hospital
• Daniel Freeman Memorial Hospital
• Cancer Care Consultants Medical Associates at Daniel Freeman Memorial Hospital
• Centinela Hospital
• Centinela Freeman Memorial Hospital
• Centinela Hospital Medical Center
• United Medical Research Institute
• 310 Clinical Research
• Research Site
• Novo Nordisk Investigational Site
• Axon Clinical Research
• Chrishard Medical Group

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gambro Healthcare - Inglewood?

Gambro Healthcare - Inglewood has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gambro Healthcare - Inglewood conducted?

Gambro Healthcare - Inglewood has 1 clinical trials on record. Their work covers End-Stage Kidney Disease.

Is Gambro Healthcare - Inglewood accredited by Crixeo Clinical Trials?

Gambro Healthcare - Inglewood has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gambro Healthcare - Inglewood?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.